2.165

2.48% -0.055

Tenaya Therapeutics Inc (TNYA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.22

Offen:

$2.24

24-Stunden-Volumen:

2.35M

Relative Volume:

1.19

Marktkapitalisierung:

$169.93M

Einnahmen:

Nettoeinkommen (Verlust:

$-117.23M

KGV:

-0.9709

EPS:

-2.23

Netto-Cashflow:

$-95.25M

1W Leistung:

+7.18%

1M Leistung:

+12.76%

6M Leistung:

-48.21%

1J Leistung:

+19.61%

1-Tages-Spanne:

$2.08

$2.24

1-Wochen-Bereich:

$1.91

$2.51

52-Wochen-Spanne:

$1.61

$7.01

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Firmenname

Tenaya Therapeutics Inc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

415-865-2066

Adresse

171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO

Mitarbeiter

140

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

TNYA's Discussions on Twitter

Vergleichen Sie TNYA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TNYA	2.1635	169.93M	0	-117.23M	-95.25M	-2.23
VRTX	450.00	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	748.66	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	588.46	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.13	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.53	24.89B	3.30B	-501.07M	1.03B	11.54

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-06-15	Eingeleitet	H.C. Wainwright	Buy

Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten

Nov 19, 2024

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Nov 19, 2024

Tenaya Therapeutics Issues Stock Options to New Employees at $1.97 Per Share | TNYA Stock News - StockTitan

Nov 19, 2024

Nov 18, 2024

Tenaya Therapeutics SVP sells $4,786 in stock - Investing.com

Nov 18, 2024

Nov 15, 2024

RA Capital Management's Strategic Acquisition in Tenaya Therapeu - GuruFocus.com

Nov 15, 2024

Nov 11, 2024

Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) large institutional owners must be happy as stock continues to impress, up 42% over the past week - Simply Wall St

Nov 10, 2024

Nov 07, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Price Target Lowered to $18.00 at Chardan Capital - MarketBeat

Nov 07, 2024

Nov 06, 2024

Latham Group, Inc. to Participate in the Baird 2024 Global Industrial Conference - The Manila Times

Nov 06, 2024

Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 06, 2024

Nov 05, 2024

abrdn plc Invests $1.06 Million in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - MarketBeat

Nov 05, 2024

Nov 04, 2024

BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com

Nov 04, 2024

Beam Therapeutics (BEAM) Stock Surges with Strong Trading Volume - GuruFocus.com

Nov 04, 2024

Nov 03, 2024

Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Nov 03, 2024

Nov 01, 2024

Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation - Yahoo Finance

Nov 01, 2024

Oct 31, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Oct 31, 2024

Oct 30, 2024

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Oct 30, 2024

Oct 19, 2024

Piper Sandler raises confidence in Tenaya Therapeutics stock ahead of December data, reiterates Overweight rating - Investing.com Australia

Oct 19, 2024

Oct 18, 2024

Tenaya shares retain stock target, buy rating on safety milestone - Investing.com

Oct 18, 2024

Tenaya shares hold buy rating, positive outlook on trial progress - Investing.com

Oct 18, 2024

Tenaya Therapeutics' (TNYA) "Buy" Rating Reiterated at Canaccord Genuity Group - MarketBeat

Oct 18, 2024

Leerink sees Tenaya's trial update as positive, maintains price target By Investing.com - Investing.com UK

Oct 18, 2024

Tenaya stock undervalued despite strong Ph1 safety update, says Canaccord - Investing.com

Oct 18, 2024

Tenaya (TNYA) Experiences Notable Stock Increase Following Key Update - Stocks Telegraph

Oct 18, 2024

Tenaya shares hold buy rating, positive outlook on trial progress By Investing.com - Investing.com UK

Oct 18, 2024

Oct 17, 2024

Tenaya advances gene therapy trial for heart condition - Investing.com

Oct 17, 2024

Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM - GlobeNewswire

Oct 17, 2024

Oct 10, 2024

SVP, Accounting and Fin. Ops. Saito Chihiro sold 2,363 shares of Tenaya Therapeutics Inc [TNYA] - Knox Daily

Oct 10, 2024

Oct 09, 2024

Tenaya Therapeutics stock hits 52-week low at $1.63 By Investing.com - Investing.com Canada

Oct 09, 2024

Oct 08, 2024

Technical analysis of Tenaya Therapeutics Inc (TNYA) stock chart patterns - US Post News

Oct 08, 2024

Oct 07, 2024

A Closer Look at Tenaya Therapeutics Inc (TNYA) Stock Gains - The InvestChronicle

Oct 07, 2024

Oct 05, 2024

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Rating of "Buy" by Brokerages - MarketBeat

Oct 05, 2024

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of “Buy” by Brokerages - Defense World

Oct 05, 2024

Oct 04, 2024

Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing - Barchart

Oct 04, 2024

Oct 03, 2024

Charting the Course: Tenaya Therapeutics Inc’s TNYA Stock Prospects - The InvestChronicle

Oct 03, 2024